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http:WHAT THIS PAPER ADDS
This paper reports the impact of an optimized spinal cord protection strategy on spinal cord ischemia rates after
endovascular thoracoabdominal aneurysm repair performed in a high volume center.Objective/background: Spinal cord ischemia (SCI) is a devastating complication following endovascular
thoracoabdominal aortic aneurysm (TAAA) repair. In an attempt to reduce its incidence two peri-procedural
changes were implemented by the authors in January 2010: (i) all large sheaths are withdrawn from the iliac
arteries immediately after deploying the central device and before cannulation and branch extension to the
visceral vessels; (ii) the peri-operative protocol has been modiﬁed in an attempt to optimize oxygen delivery to
the sensitive cells of the cord (aggressive blood and platelet transfusion, median arterial pressure monitoring
>85 mmHg, and systematic cerebrospinal ﬂuid drainage).
Methods: Between October 2004 and December 2013, 204 endovascular TAAA repairs were performed using
custom made devices manufactured with branches and fenestrations to maintain visceral vessel perfusion. Data
from all of these procedures were prospectively collected in an electronic database. Early post-operative results
in patients treated before (group 1, n ¼ 43) and after (group 2, n¼ 161 patients) implementation of the modiﬁed
implantation and peri-operative protocols were compared.
Results: Patients in groups 1 and 2 had similar comorbidities (median age at repair 70.9 years [range 65.2e77.0
years]), aneurysm characteristics (median diameter 58.5 mm [range 53e65 mm]), and length of procedure
(median 190 minutes [range 150e240 minutes]). The 30 day mortality rate was 11.6% in group 1 versus 5.6% in
group 2 (p ¼ .09). The SCI rate was 14.0% versus 1.2% (p < .01). If type IV TAAAs were excluded from this
analysis, the SCI rate was 25.0% (6/24 patients) in group 1 versus 2.1% (2/95 patients) in group 2 (p < .01).
Conclusion: The early restoration of arterial ﬂow to the pelvis and lower limbs, and aggressive peri-operative
management signiﬁcantly reduces SCI following type IeIII TAAA endovascular repair. With the use of these
modiﬁed protocols, extensive TAAA endovascular repairs are associated with low rates of SCI.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The repair of descending thoracic and thoracoabdominal
aortic aneurysms (TAAAs) exposes the spinal cord to
ischemic injuries with resultant paraplegia or paraparesis.1
Although intuitively less invasive than open repair, endo-
vascular thoracic and TAAA repairs are nonetheless still
associated with high rates of spinal cord ischemia (SCI),responding author.
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//dx.doi.org/10.1016/j.ejvs.2014.11.017described, in a recent meta-analysis, in up to 13% of pa-
tients after thoracic endovascular aortic repair (TEVAR).2
The mechanisms that cause SCI are thought to be infarc-
tion secondary to absolute low perfusion (loss of intercostals
and poor collateral supply); reperfusion injury after transient
per-procedural low perfusion; and microembolic “trash”
arising from intra-aortic manipulation. The ﬁrst two are
theoretically amenable to modiﬁcation by adjunctive thera-
pies.While TEVAR has been studied, few reports to date have
focused on SCI after TAAA endografting when evaluating
these protocols aimed at spinal cord protection.3,4
A branched and fenestrated endograft programme for
the treatment of atherosclerotic TAAA and chronic
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diologique, CHRU de Lille, in 2004. Before 2009, <20
endovascular TAAA repairs were performed annually. After
2009 the number of procedures increased to >30 annually.
At the beginning of 2010 the endograft implantation tech-
nique (early restoration of blood ﬂow to the pelvis and the
lower limbs as soon as aortic components are implanted)
was changed and a routine per- and post-operative proac-
tive spinal cord protective protocol was adopted.
The purpose of this analysis was to assess the clinical
impact of these spinal cord protective protocols.
METHODS
All TAAA endovascular repairs performed at the Aortic
Centre, Hôpital Cardiologique, CHRU de Lille, between
October 2004 and December 2013 were identiﬁed from a
prospectively maintained electronic endovascular aortic
database. Demographics, medical history, and procedure
related data were extracted for analysis. The time of onset
and severity of the neurologic deﬁcit were determined by
review of the electronic medical charts. Complications were
deﬁned using the Society for Vascular Surgery’s reporting
standards for endovascular aortic aneurysm repair.5 Emer-
gency procedures were excluded from the current analysis.
The Crawford classiﬁcation system was used to categorize
the extent of the aortic coverage by the endograft (IeIV).6e
8 Patients with three fenestrations (both renals and superior
mesenteric artery [SMA]) and one scallop for the celiac
trunk (CT), and a >20 mm proximal sealing zone above the
SMA were included in the type IV TAAA group. Patients with
type IeIII TAAAs treated between February 2010 and March
2012 were included in the “Windows 2” prospective
multicenter trial.9
Patient groups
Patients treated between 2004 and 2009 were included in
group 1, and those treated from 2010 to 2013 were
included in group 2. Since 2010, >30 TAAA endovascular
repairs have been performed at the Aortic Centre, Hôpital
Cardiologique, CHRU de Lille, annually. The year 2010 also
coincides with the optimization of the device implantation
technique and the systematic application of the proactive
spinal cord protective protocol as described below.
Endovascular technique
One experienced vascular surgeon performed or supervised
all of the procedures (S.H.). Prior to December 2012, all
cases were performed in an operating room with a mobile
motorized C-Arm (OEC 9900 Elite MD; GE OEC Medical
Systems, Inc., Salt Lake City, UT, USA). More recently, they
have been performed in a dedicated hybrid operating room
(Discovery; GE Healthcare, Chalfont St Giles, UK) under
image fusion guidance. The endovascular devices were all
custom made three or four branched or fenestrated
endografts, with proximal thoracic and/or distal abdominal
bifurcated extensions when required. A dose of 100 UI/kg of
intravenous heparin was injected at the beginning of theprocedure. The anticoagulation was monitored by activated
clotting time (ACT). The ACT target was >250 seconds
during the entire procedure. A detailed description of the
implantation procedure for fenestrated procedures has
been published previously.10
Implantation protocol
In all cases, the branch/fenestration bearing component
was implanted, and any fenestrations (cannulation and
stenting) were completed in cases with a combination of
fenestration(s) and branch(es). In group 1, any branches
were then completed by implantation of the bridging stents
into their respective branches from an axillary artery
approach. Finally, procedures were completed by implan-
tation of the bifurcated body and iliac limbs. Critically, the
large sheaths were not withdrawn from the femoral and
iliac arteries before the end of the procedure. In group 2,
however, the implantation sequence was changed so that
after implantation of the branch/fenestration bearing
component and completion of any fenestrations, the
bifurcated body and limb extensions were immediately
completed to allow the early withdrawal of the large caliber
(iliac occlusive) sheaths in order to permit the early resto-
ration of blood ﬂow to the pelvis and lower limbs and to
reduce ischemia/reperfusion damage. The branches were
then completed from an axillary arterial access as the ﬁnal
step.10
Staged and adjunctive procedures to preserve spinal cord
ﬂow in group 2
Following the demonstration of the potentially beneﬁcial
effects of a staged repair to encourage spinal cord pre-
conditioning during extensive TAAA repair,11 the thoracic
endovascular component was implanted during the ﬁrst
procedure in all cases in which the anatomy was suitable
(i.e., when a distal sealing zone with a maximum diameter
<42 mm was present). Every effort was made to maintain
the perfusion of at least one internal iliac artery (IIA); if
required, iliac branched devices were employed. When left
subclavian artery (LSA) coverage was deemed necessary for
proximal seal, carotid subclavian transposition or bypass
was performed as an initial procedure. These “ﬁrst stage”
procedures were performed 6e10 weeks before deﬁnitive
TAAA repair.
Proactive spinal cord protective protocol in group 2
Cerebrospinal ﬂuid drainage. Since January 2010, a pre-
operative cerebrospinal ﬂuid (CSF) drain has been system-
atically established for all TAAA types IeIII (not for type IV).
A spinal drain is inserted in the operating room by a dedi-
cated cardiovascular anesthesiology team. Owing to the risk
of compressive neuraxial hematoma, the French Society of
Anesthesiology recommends a minimum 6 hour delay be-
tween the placement of the CSF drain and injection of
heparin. It is thus more convenient to place the spinal drain
the day before the procedure.12 CSF pressure was main-
tained at <10 cmH2O during and for at least 48 hours after
Figure 1. Number of patients treated annually.
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positioning was performed in the intensive care unit (ICU)
to avoid subdural bleeding and excessive CSF drainage. In
patients without clinical evidence of SCI, CSF drains were
removed 48 hours after the procedure. In the setting of
documented SCI, CSF pressure was dropped to <5 cmH2O
and the drain was removed after neurologic recovery (or at
a maximum of 5 days after the procedure).
Pre-emptive use of blood products. At the end of the
procedure, blood, plasma, and platelet transfusions were
performed to avoid post-operative coagulopathy and blood
loss. Fresh frozen plasma was transfused at 15 mL/kg and at
least one pool of platelets was given, with therapeutic
targets of hemoglobin >10 g/dL; prothrombin time >50%;
plasma ﬁbrinogen >2 g/L; and >100 G/L platelets.
Hemodynamic minima. Volume resuscitation and vasoac-
tive support were administered to maintain a mean arterial
pressure of 85e90 mmHg (invasive hemodynamic moni-
toring) and a central venous oxygen saturation >75% after
endograft deployment.
Post-operative care. All patients were admitted to a dedi-
cated cardiovascular ICU for continuous hemodynamic
monitoring and hourly lower limb neurological assessment
for at least the ﬁrst 48 post-operative hours.
SCI diagnosis and management
SCI was deﬁned as any new lower extremity motor or
sensory deﬁcit not attributable to other causes (epidural
hematoma, intracranial pathology, peripheral neuropathy),
and then further categorized according to a previously
described neurologic deﬁcit scoring system into paraplegia
or paraparesis.13 Patients who had a change in their pre-
operative neurologic status noted at the ﬁrst post-
operative examination were considered to have immedi-
ate SCI, whereas those who experienced an interval of
normal post-operative neurological function, followed by a
deﬁcit, were considered to have a delayed presentation.
When SCI was identiﬁed, a neurology consultation and
magnetic resonance imaging (MRI) or an electromyogram (if
MRI was not interpretable) was obtained.
End points
Primary end points included post-operative SCI, 30 day
major and minor complications, and 30 day mortality.
Mortality at 1 year was also recorded for patients operated
on prior to December 2012.
Statistical analysis
Data were reported as median and 25e75% interquartile
ranges and frequencies. Variables were compared between
the two groups using the Fisher exact test for discrete data
and the ManneWhitney test for continuous data. The
groups were comparable with respect to age and comor-
bidities, and logistic regression analysis was therefore not
performed. Because the most important factor thatcontributed to surgical risk was the extent of the
aneurysmal disease, an analysis according to Crawford
subgroup, excluding type IV TAAA endovascular repair (with
the least risk of SCI),14 was performed. Values of p < .05
were considered to be statistically signiﬁcant. All analyses
were conducted using Epi Info 3.5.3. software (Centers for
Disease Control and Prevention, Atlanta, GA, USA).
RESULTS
Patient demographics and operative details
Between 2004 and December 2013, 204 endovascular re-
pairs of TAAAs were performed (Fig. 1). The total number of
fenestrations was 523, including 322 renal, 147 SMA, and 54
CT fenestrations. The total number of branches was 172,
comprising 64 renal, 54 SMA and 54 CT branches. Purely
fenestrated endografts were implanted in 138 patients (23
in group 1 and 115 in group 2) and branched endografts in
33 patients (10 in group 1 and 23 in group 2). The remaining
33 patients were treated with grafts combining branches
and fenestrations. Five (2.5%) type I, 38 type II (18.6%), 76
type III (37.3%), and 85 type IV (41.7%) TAAAs were treated.
Between October 2004 and December 2009, 43 patients
with TAAAs were treated (group 1), and between January
2010 and December 2013 a further 161 patients were
treated (group 2). Patient demographic characteristics are
summarized in Table 1. The groups were comparable with
respect to age and comorbidities.Thirty day outcomes
Peri-operative outcomes are given in Table 2. The overall 30
day mortality rate was 6.9%, the major complication rate
was 26.5%, and the rate of SCI was 3.9%. The median length
of procedure (skin to skin time) was 190 minutes (range
150e240 minutes) in group 1 and 180 minutes (range 150e
225 minutes) in group 2 (p < .01). Major complications
were aortic/iliac rupture (n ¼ 2, 1%); SMA stent occlusion/
stenosis (n ¼ 3, 1.5%); access site major hematoma (n ¼ 3,
1.5%); peripheral macroembolization (requiring embolec-
tomy) (n ¼ 5, 2.5%); access site infection (requiring
drainage) (n ¼ 2, 1%); endograft infection (n ¼ 3, 1.5%);
multi-organ failure (MOF; n ¼ 7, 3.4%); SCI (n ¼ 8, 3.9%);
renal failure (requiring dialysis/ﬁltration) (n ¼ 11, 5.4%,
including ﬁve patients with MOF); pulmonary infection
Table 1. Patient demographics.
Group 1 (n ¼ 43) Group 2 (n ¼ 161) p
Age (range) at repair (y) 72 (64.7e77.0) 70.8 (65.3e76.9) .97
BMI (range) 27.1 (24.4e29.0) 27.1 (24.6e29.9) .83
Male 40 (93.0) 149 (92.5) .61
Maximal aortic diameter (mm) (range) 60 (54e66) 57 (53e65) .20
Atrial ﬁbrillation 5 (11.6) 21 (13.0) .42
Previous aortic surgery 15 (34.0) 45 (28.0) .20
LVEF < 40% 2 (4.7) 10 (6.2) .52
Diabetes mellitus 6 (14.0) 31 (19.3) .29
CAD/CABG/coronary stent 21 (48.8) 71 (44.1) .35
High blood pressure 32 (74.4) 131 (81.4) .21
Dyslipidemia 22 (51.2) 99 (62.5) .15
GFR < 60 mL/min (Cockcroft) 10 (23.3) 40 (25.0) .49
Smoking, active/history 34 (81.0) 132 (82.0) .52
Stroke 4 (9.3) 24 (14.0) .25
COPD 17 (39.0) 59 (36.6) .43
Note. Values are given as n (%) unless otherwise indicated. BMI ¼ body mass index; LVEF ¼ left ventricular ejection fraction;
CAD ¼ coronary artery disease; CABG ¼ coronary artery bypass graft; GFR ¼ glomerular ﬁltration rate; COPD ¼ chronic obstructive
pulmonary disease.
Impact of Early Pelvic and Lower Limb Reperfusion 251(n ¼ 9, 4.4%); bacteremia (n ¼ 5, 2.5%); cardiac failure/
arrest (n ¼ 7, 3.4%); stroke (n ¼ 2, 1%); bowel/hepatic
ischemia (n ¼ 3, 1.5%); and pulmonary embolism (n ¼ 1,
0.5%). Five type I (2.5%) and two (1.0%) type III endoleaks
were observed. The primary technical success rate was
92.6% (90.7% in group 1 and 93.2% in group 2).
Comparison between groups 1 and 2 revealed a signif-
icant difference in the incidence of SCI (14.0% vs. 1.2%
respectively; p < .001). There were no major complica-
tions (intracranial hemorrhage) due to CSF drainage. In
group 1, 24 patients were treated for type IeIII TAAAs;
among these patients, 33.0% (8/24) had pre-operative
spinal cord drainage. None of them had a staged proce-
dure. In group 2, 95 patients were treated for type IeIII
TAAAs; among these patients, 12.6% (12/95 patients) had
a staged repair. The ﬁrst procedure included seven
TEVARs, one iliac conduit, three supra-aortic trunk
debranching, four LSA transpositions and one renal
fenestration.Thirty day outcomes after type IeIII TAAA repair
The exclusion of the relatively low risk type IV TAAAs from
analysis reveals a signiﬁcant difference with regard to SCI
rate (Table 3): 25.0% (6/24 patients) in group 1 versus 2.1%
(2/95 patients) in group 2 (p < .001); a signiﬁcant reduction
in major complication rates (50.0% vs. 28.4%; p ¼ .04);
signiﬁcantly longer procedure length in patients who suf-
fered SCI in both groups (300 minutes [range 300e360
minutes] vs. 240 minutes [range 210e290 minutes] in
group 1 [p ¼ .01]; 400 minutes [range 290e510 minutes]Table 2. Thirty day complication rates.
Total (n ¼ 204) Group 1 (n ¼ 43)
Major complications 54 (26.5) 15 (34.9)
Spinal cord ischemia 8 (3.9) 6 (14.0)
30 day mortality 14 (6.9) 5 (11.6)
Minor complications 56 (27.5) 12 (27.9)
Note. Values are given as n (%). RR ¼ relative risk; CI ¼ conﬁdence invs. 210 minutes [range 170e240 minutes] in group 2
[p ¼ .04]) than in those who remained neurologically intact.Spinal cord injury
In total, SCI occurred in eight (3.9%) patients (Table 4). One
died within 30 days and two others within a year of their
procedure; one patient had no recovery and two others had
partial recovery (able to walk alone with a stick). The two
patients with delayed paraparesis experienced complete
neurological recovery. All patients were transferred to a
dedicated rehabilitation center. Peri-operative risk factors
for SCI were identiﬁable in all cases: hemorrhagic/hemo-
dynamic shock in four patients, extensive thoracic aortic
coverage in all patients, IIA thrombosis in three patients
(unilateral in two patients and bilateral in one), and renal
insufﬁciency in one patient. Previous infrarenal abdominal
aortic aneurysm repair was not a risk factor for SCI in this
study.Windows 2 results
This study included 23 patients who were part of a multi-
center French trial (Windows 2) between February 2010
and March 2012 (all drawn from group 2 in the current
study).9 All were type IeIII TAAA repairs. This subgroup
experienced six (26.1%) major complications, 10 (43.5%)
minor complications, no 30 day mortality (0%), no SCI (0%),
and six (26.1%) deaths at 1 year (three were considered in
hospital deaths: acute renal failure, pneumonia, and aorticGroup 2 (n ¼ 161) RR (95% CI) p
39 (24.2) 1.1637 (0.9195e1.4728) .11
2 (1.2) 1.1477 (1.0163e1.2961) <.01
9 (5.6) 0.4807 (0.1699e1.3604) .15
44 (27.3) 1.0080 (0.8181e1.2420) .54
terval.
Table 3. Thirty day outcomes of patient with type I, II, and III thoracoabdominal aortic aneurysms.
Group 1 (n ¼ 24) Group 2 (n ¼ 95) RR (95% CI) p
Major complications 12 (50.0) 27 (28.4) 1.4316 (0.9409e2.1781) .04
Spinal cord ischemia 6 (25.0) 2 (2.1) 1.3053 (1.0341e1.6475) <.001
30 day mortality 5 (20.8) 7 (7.4) 0.3537 (0.1229e1.10175) .06
Minor complications 8 (33.3) 30 (31.9) 1.0213 (0.7454e1.3993) .54
Note. Values are given as n (%). RR ¼ relative risk; CI ¼ conﬁdence interval.
252 B. Maurel et al.rupture due to endograft infection 43, 167, and 103 days
after the initial procedure, respectively).
One year survival
The overall 1 year survival among patients treated before
2013 was 122/149 (81.9%) for the whole group, 37/43
(86%) in group 1, and 85/106 (80.2%) in group 2 (p ¼ .28).
There was only one (1.0%) aneurysm related death in group
2, 103 days after the initial procedure as a consequence of
an endograft infection.
DISCUSSION
This study describes the second largest published cohort of
patients treated for TAAA using endovascular repair in a
single, high volume center. Outcomes for patients treated at
the beginning of the experience have been speciﬁcally
compared with those treated after the initial “learning
curve”. The inﬂuence of a group of factors has been
examined: the onset of a high annual experience (>30
procedures annually); a change in the device deployment
sequence (speciﬁcally intended to produce an early resto-
ration of blood ﬂow to the pelvis); the application of an
aggressive, per- and post-operative protocol (designed to
optimize spinal cord perfusion). When comparing these two
groups, it was observed that this combination of factors isTable 4. Detailed description of all spinal cord ischemia.
Group TAAA
type
Risk factors CSF drainage Per-operative
risk
factors
1 II None Pre-operative TEVAR (n ¼ 1)
Iliac rupture an
massive bleedi
1 III IIA thrombosis
(n ¼ 1)
No TEVAR (n ¼ 1)
Contralateral A
thrombosis
1 I Clearance < 60 Post-
operative
TEVAR (n ¼ 1)
Severe bleedin
1 II None Pre-operative TEVAR (n ¼ 2)
1 II Bilateral IIA
thrombosis
No TEVAR (n ¼ 2)
1 III None Post-
operative
TEVAR (n ¼ 1)
2 III Obesity
(BMI 48.5)
Pre-operative TEVAR (n ¼ 1)
2 II IIA thrombosis
(n ¼ 1)
Pre-operative TEVAR (n ¼ 2)
Note. TAAA ¼ thoracoabdominal aortic aneurysm; CSF ¼ cerebrosp
TEVAR ¼ thoracic endovascular aortic repair; MOF ¼ multi-organ failu
a Thirty day mortality.
b One year mortality.associated with a reduced incidence of SCI. A signiﬁcant
reduction in the frequency of major complications when
treating type IeIII TAAAs (but not type IV) was also
observed.
The object of an effective spinal protection protocol is to
prevent nerve cell death by preserving perfusion at cellular
level and by reducing cellular metabolic demand. As spinal
cord oxygen delivery is a compound of hemodynamic and
oxygen content factors, it is therefore likely that augmen-
tation of the cardiac function and reduction of the CSF
pressure are key factors in optimal spinal perfusion.15 At
present, there is little consensus regarding the role of CSF
drainage.2 In a meta-analysis, series reporting routine,
none, or selective prophylactic drain placement reported
pooled SCI rates of 3.2%, 3.47%, and 5.6%, respectively.2
This useful adjunct also carries the risk of intracranial
hemorrhage.16 Prophylactic CSF drainage was routinely
performed pre-operatively before type IeIII TAAA repair in
the later experience: the patients suffered no major
complication attributable directly to CSF drainage and SCI
rates were reduced, although it is not possible to determine
the distinct role of CSF drainage from the protective stra-
tegies employed as a package.
In addition to universal CSF drainage, a pre-emptive
strategy of blood, plasma and platelet transfusions wasPost-operative
risk factors
Neurologic deﬁcit
Onset Severity Recovery
d
ng
MOF Immediate Paraplegia Noa
II
None Delayed (10 d) Fluctuating
paraparesis
Complete
g
Hypotension
Anemia
Immediate Paraplegia Nob
None Immediate Paraparesis Incomplete
Retroperitoneal
hematoma
Delayed (2 d) Paraplegia Incomplete
None Immediate Paraplegia Incomplete
Anemia
MOF
Delayed (11 d) Paraplegia Nob
None Delayed (2 d) Paraparesis Complete
inal ﬂuid; IIA ¼ internal iliac artery; BMI ¼ body mass index;
re.
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extensive endovascular exclusion in large aneurysms is
associated with massive blood sequestration between the
aneurysmal aortic wall and the endograft. This results in an
acute reduction in coagulation factors and platelets, which
gives rise to a variety of coagulation disorders that
contribute to severe bleeding.17 Secondly, a maximization
of oxygen delivery was attempted, in part based on an
increased cardiac output.3 Finally, perfusion with oxygen or
hemoglobin depleted blood is physiologically valueless. A
high hemoglobin level (at least 10 g/dL) and SaO2 >95%,
were therefore ensured. In addition, early pelvic and leg
reperfusion is aimed for by the early removal of large
femoral sheaths in order to reduce the pelvic and the lower
limb ischemia time, and therefore reduce the likelihood and
severity of any ischemia/reperfusion syndrome.
The “collateral network concept” includes the idea of a
remodeling process driven by pressure gradients across
paraspinal collaterals.18 This implies that a “staged approach”
has the potential to reduce SCI by arteriogenic pre-
conditioning.11 This concept was introduced into the authors’
clinical practice in 2010, and a “staged approach” was per-
formed in 12/95 (12.6%) patients with type IeIII TAAAs.
A signiﬁcant reduction in the SCI rate after TAAA repair
has been observed, from 14.0% in the authors’ early
experience to 1.2% in their later experience. The majority of
this improvement is ascribed to the routine application of
all of the neuroprotective strategies described above as a
package. The “learning curve” is more than a technical ex-
ercise, but it is likely that there is beneﬁt to be gained from
high case volumes and improving technical expertise. It has
been widely reported that an important determinant of
operative outcome is the volume of TAAA repairs.19
Study limitations
Most of these data were collected from a prospectively
maintained electronic database but some details were
gleaned from other, less reliable sources. For example,
complete hemodynamic data for the period after patients
were discharged from ICU (two patients developed SCI after
discharge from the ICU) was not obtained. As these data
describe a single, high volume centre experience, a multi-
center study is required before advocating more deﬁnitive
conclusions regarding the optimal spinal cord protection
strategies that have been employed in this study. The spe-
ciﬁc role of each component of the SCI protection package
has not been dissected because, at this stage of the expe-
rience, it is considered that the use of all of the components
is both complimentary and important. As previously
detailed, a number of changes have been made that have
resulted in a signiﬁcant reduction in the rates of SCI; it is not
possible to evaluate how much each change has contrib-
uted to the improved results.
Conclusion
A spinal cord protection strategy, based on an optimization
of the implantation procedure (including early restorationof pelvic and lower limb blood ﬂow, aggressive revascular-
ization of the LSA and the IIA, and performing staged repairs
whenever possible) together with systematic CSF drainage,
assiduous blood pressure management, and a strategy of
pre-emptive of blood, plasma, and platelet transfusion, has
been improved. This proactive spinal cord protective pro-
tocol associated with a high volume practice has signiﬁ-
cantly reduced the incidence of SCI after TAAA
endovascular repair.
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I. Koncar a,b,c,*, L. Davidovic a,b
a Clinic for Vascular and Endovascular Surgery, Serbian Clinical Centre, University of Belgrade, Serbia
bMedical Faculty, University of Belgrade, Serbia
c Faculty of Engineering, University of Kragujevac and BioIRCKragujevac, SerbiaAn 81-year-old woman was admitted with back pain and a 68-mm abdominal aortic aneurysm (AAA). Intraoperatively, an
area of imminent rupture was found at the left antero-lateral AAA wall (left image). A patient-speciﬁc geometric model of
the AAA was created using CFDVasc software, which showed that the highest level of wall stress in the antero-lateral aortic
wall was low (21.2 N/m2) (right image). This suggests that high levels of wall stress are not always related to the location
and risk of AAA rupture. Both the quality of the aortic wall and the biochemical activity might play important roles
